Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Sung Moon

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Diabetes & Metabolism Journal|December 3, 2023
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 StudyJun Sung Moon, Il Rae Park, Sang Soo Kim, et al.
Diabetes & Metabolism Journal|June 10, 2018
The Changes of Trends in the Diagnosis and Treatment of Diabetic Foot Ulcer over a 10-Year Period: Single Center StudyChoong Hee Kim, Jun Sung Moon, Seung Min Chung, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trialNam Hoon Kim, Jun Sung Moon, Yong-Ho Lee, et al.
Plos One|November 27, 2023
Predictive factors of lymph node metastasis in papillary thyroid cancerWoo Jin Song, In Chan Um, Sa Rang Kwon, et al.
Diabetes & Metabolism Journal|December 17, 2025
Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical TrialYong-Ho Lee, Kyung Wan Min, Jun Hwa Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|January 6, 2023
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine SocietyHyemi Kwon, Eun Roh, Chang Ho Ahn, et al.
Endocrinology and Metabolism (Seoul, Korea)|August 16, 2021
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine SocietyCheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, et al.
Diabetes & Metabolism Journal|June 20, 2022
Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing SurveillanceJun Sung Moon, Nam Hoon Kim, Jin Oh Na, et al.
Frontiers in Physiology|July 11, 2022
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting StrategiesMohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, et al.
Diabetes Research and Clinical Practice|June 21, 2026
The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitusHun Jee Choe, Bo Kyung Koo, Yoon-Ho Hong, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Diabetes & Metabolism Journal|December 3, 2023
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 StudyJun Sung Moon, Il Rae Park, Sang Soo Kim, et al.
Diabetes & Metabolism Journal|June 10, 2018
The Changes of Trends in the Diagnosis and Treatment of Diabetic Foot Ulcer over a 10-Year Period: Single Center StudyChoong Hee Kim, Jun Sung Moon, Seung Min Chung, et al.
Diabetes, Obesity & Metabolism|June 10, 2024
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trialNam Hoon Kim, Jun Sung Moon, Yong-Ho Lee, et al.
Plos One|November 27, 2023
Predictive factors of lymph node metastasis in papillary thyroid cancerWoo Jin Song, In Chan Um, Sa Rang Kwon, et al.
Diabetes & Metabolism Journal|December 17, 2025
Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical TrialYong-Ho Lee, Kyung Wan Min, Jun Hwa Hong, et al.
Endocrinology and Metabolism (Seoul, Korea)|January 6, 2023
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine SocietyHyemi Kwon, Eun Roh, Chang Ho Ahn, et al.
Endocrinology and Metabolism (Seoul, Korea)|August 16, 2021
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine SocietyCheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, et al.
Diabetes & Metabolism Journal|June 20, 2022
Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing SurveillanceJun Sung Moon, Nam Hoon Kim, Jin Oh Na, et al.
Frontiers in Physiology|July 11, 2022
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting StrategiesMohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, et al.
Diabetes Research and Clinical Practice|June 21, 2026
The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitusHun Jee Choe, Bo Kyung Koo, Yoon-Ho Hong, et al.
Pageof 11